Augmented cell survival in eutopic endometrium from women with endometriosis: Expression of c-myc, TGF-beta1 and bax genes
Open Access
- 8 September 2005
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 3 (1) , 45
- https://doi.org/10.1186/1477-7827-3-45
Abstract
Endometriosis is a common gynaecological disorder characterized by the presence of endometrial tissue outside of the uterus. The fragments in normal menstruation are composed of necrotic and living cells, which do not survive in ectopic locations because of programmed cell death. The aim of this study was to evaluate if the balance between cell proliferation and apoptosis is changed in eutopic endometrium from women with endometriosis throughout the menstrual cycle by studying bax (pro-apoptotic), c-myc (regulator of cell cycle) and TGF-beta1 (involved in cell differentiation) genes. Eutopic endometrium was obtained from: 30 women with endometriosis (32.8 +/- 5 years) and 34 fertile eumenorrheic women (36 +/- 5.3 years). We analyzed apoptosis (TUNEL: DNA fragmentation); cell proliferation (immunohistochemistry (IHC) for Ki67); c-myc, bax and TGF-beta1 mRNA abundance (RT-PCR) and TGF-beta1 protein (IHC) in endometrial explants. Cell proliferation strongly decreased from proliferative to late secretory phases in glands, but not in stroma, in both endometria. Positive staining in glands and stroma from proliferative endometrium with endometriosis was 1.9- and 2.2-fold higher than control endometrium, respectively (p < 0.05). Abundance of c-myc mRNA was 65% higher in proliferative endometrium from endometriosis than normal tissue (p < 0.05). TGF-beta1 (mRNA and protein) augmented during mid secretory phase in normal endometrium, effect not observed in endometrium with endometriosis. In normal endometrium, the percentage of apoptotic epithelial and stromal cells increased more than 30-fold during late secretory phase. In contrast, in endometrium from endometriosis, not only this increase was not observed, besides bax mRNA decreased 63% versus normal endometrium (p < 0.05). At once, in early secretory phase, apoptotic stromal cells increased 10-fold with a concomitant augment of bax mRNA abundance (42%) in endometria from endometriosis (p < 0.05). An altered expression of c-myc, TGF-beta1 and bax was observed in eutopic endometrium from endometriosis, suggesting its participation in the regulation of cell survival in this disease. The augmented cell viability in eutopic endometrium from these patients as a consequence of a reduction in cell death by apoptosis, and also an increase in cell proliferation indicates that this condition may facilitate the invasive feature of the endometrium.Keywords
This publication has 44 references indexed in Scilit:
- P450 arom y microambiente estrogénico en endometrios eutópicos de mujeres con endometriosisRevista médica de Chile, 2004
- Reduction of apoptosis and proliferation in endometriosisFertility and Sterility, 2004
- Identification of estrogen-responsive genes in the GH3 cell line by cDNA microarray analysisThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Concerted effect of transforming growth factor-β, cyclin inhibitor p21, and c-mycon smooth muscle cell proliferationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle ArrestCancer Research, 2004
- Mad Upregulation and Id2 Repression Accompany Transforming Growth Factor (TGF)-β-mediated Epithelial Cell Growth SuppressionJournal of Biological Chemistry, 2003
- Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosisFertility and Sterility, 2002
- Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosisFertility and Sterility, 2000
- Apoptosis and apoptosis-related proteins in human endometriumMolecular and Cellular Endocrinology, 2000
- CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumorsJournal of Clinical Endocrinology & Metabolism, 1994